No Data
No Data
Does Yantai Dongcheng Pharmaceutical GroupLtd (SZSE:002675) Have A Healthy Balance Sheet?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to consider debt, when you think about how risky any given stock is, because too
Dongcheng Biochemicals' Unit Gets Nod to Register Coronary Artery Disease Drug
Yantai Dongcheng Biochemicals' (SHE:002675) unit, Nanjing Jiangyuan Andico Positron Research and Development, received a drug registration certificate from China's National Medical Products Administra
Yantai Dongcheng Biochemicals (002675.SZ): Technetium [99mTc] Tiludronate Injection Obtains Market Approval.
Yantai Dongcheng Biochemicals (002675.SZ) has announced that its wholly-owned subsidiary, Nanjing Jiangyuan Andico Electronic Research and Development Co., Ltd. (referred to as "Andico"), has received the approval and issuance of the registration certificate for the pharmaceutical Technetium [99mTc] Tetrofosmin Injection from the National Medical Products Administration. The Technetium [99mTc] Tetrofosmin Injection has been approved for production and sale through a drug marketing authorization application.
Express News | Yantai Dongcheng Says Unit Received "Study May Proceed Letter" From U.S. FDA on Clinical Trials of Lu-Lnc1011 for Prostate Cancer Treatment
Yantai Dongcheng Pharmaceutical Group Co.,Ltd.'s (SZSE:002675) Shareholders Might Be Looking For Exit
When close to half the companies in China have price-to-earnings ratios (or "P/E's") below 29x, you may consider Yantai Dongcheng Pharmaceutical Group Co.,Ltd. (SZSE:002675) as a stock to avoid entire
Yantai Dongcheng Biochemicals (002675.SZ) equity distribution for 2023: 1.25 yuan per 10 shares.
Yantai Dongcheng Biochemicals (002675.SZ) has announced the equity distribution plan for 2023: based on the existing total share capital of the company, a cash dividend of RMB 1.25 per 10 shares will be distributed to all shareholders. The equity distribution registration date is June 21, 2024 and the ex-dividend date is June 24, 2024.
No Data